Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines

Journal of Interferon and Cytokine Research

Volumn 19, Issue 4, 1999, Pages 393-405

  Gerecitano, John ^a   Perle, Mary Ann ^a   Vilček, Jan ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; ENDOTHELIUM CELL; ENZYME INDUCTION; GENETIC REGULATION; MELANOMA; METASTASIS; MOLECULAR CLONING; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL FUSION; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON TYPE II; KARYOTYPING; LIPOPOLYSACCHARIDES; MELANOMA, EXPERIMENTAL; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA; MURINAE;

EID: 0032930342     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314108     Document Type: Article

References (58)

1. NATHAN, C., and XIE, Q.W. (1994). Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918.
2. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
3. SCHMIDT, H.H.W., and WALTER, U. (1994). NO at work. Cell 78, 919-925.
4. XIE, Q., and NATHAN, C. (1994). The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56, 576-582.
5. MARLETTA, M.A. (1994). Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78, 927-930.
6. DENIS, M. (1994). Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55, 682-684.
7. DING, A., HWANG, S., and SCHWAB, R. (1994). Effect of aging on murine macrophages. Diminished response to IFN-gamma for enhanced oxidative metabolism. J. Immunol. 153, 2146-2152.
8. XIE, Q.W., and NATHAN, C. (1993). Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. Trans. Assoc. Am. Physicians 106, 1-12.
9. XIE, Q.W., WHISNANT, R., and NATHAN, C. (1993). Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779-1784.
10. LOWENSTEIN, C.J., ALLEY, E.W., RAVAL, P., SNOWMAN, A.M., SNYDER, S.H., RUSSELL, S.W., and MURPHY, W.J. (1993). Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90, 9730-9734.
11. XIE, Q.W., KASHIWABARA, Y., and NATHAN, C. (1994). Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
12. KAMIJO, R., HARADA, H., MATSUYAMA, T., BOSLAND, M., GERECITANO, J., SHAPIRO, D., LE. J., KOH, S.I., KIMURA. T., GREEN, S.J., et al. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
13. MARTIN, E., NATHAN. C., and XIE. Q.W. (1994). Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977-984.
14. CHATURVEDI, M.M., HIGUCHI, M., and AGGARWAL, B.B. (1994). Effect of tumor necrosis factors, interferons, interleukins. and growth factors on the activation of NF-kappa B: evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res. 13, 309-313.
15. ROCKEY, D.C., and CHUNG, J.J. (1996). Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am. J. Physiol. 271, G260-G267.
16. BRADY, T.C., CHANG, L.Y., DAY, B.J., and CRAPO, J.D. (1997). Extracellular Superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation. Am. J. Physiol. 273, L1002-L1006.
17. FLESCH, I.E., and KAUFMANN, S.H. (1991). Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59, 3213-3218.
18. LEENEN, P.J., CANONO, B.P., DREVETS, D.A., VOERMAN, J.S., and CAMPBELL, P.A. (1994). TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol. 153, 5141-5147.
19. NATHAN, C.F., and HIBBS, J., Jr. (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70.
20. NATHAN, C. (1997). Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100, 2417-2423.
21. REISS, C.S., and KOMATSU, T. (1998). Does nitric oxide play a critical role in viral infections? J. Virol. 72, 4547-4551.
22. HIBBS, J.B., Jr., VAVRIN, Z., and TAINTOR, R.R. (1987). L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138, 550-565.
23. HIGUCHI, M., HIGASHI, N., TAKI, H., and OSAWA, T. (1990). Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-argini ne-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144, 1425-1431.
24. KLOSTERGAARD, J., LEROUX, M.E., and HUNG, M.C. (1991). Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. J. Immunol. 147, 2802-2808.
25. LEU, R.W., LEU, N.R., SHANNON, B.J., and FAST, D.J. (1991). IFN-gamrna differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. J. Immunol. 147, 1816-1822.
26. JIANG, H., STEWART, C.A., FAST, D.J., and LEU, R.W. (1992). Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for rumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Immunol. 149, 2137-2146.
27. DILEEPAN, K.N., PAGE, J.C., LI, Y., and STECHSCHULTE, D.J. (1995). Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma. J. Interferon Cytokine Res. 15, 387-394.
28. XIE, K., HUANG, S., DONG, Z., JUANG, S.H., GUTMAN, M., XIE, Q.W., NATHAN, C. and FIDLER, I.J. (1995). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343.
29. KORBUT, R., and GRYGLEWSKI, R.J. (1993). Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur. J. Pharmacol. 234, 17-22.
30. RADOMSKI, M.W., PALMER, R.M., and MONCADA, S. (1990). An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87, 5193-5197.
31. XIE, K., DONG. Z., and FIDLER, I.J. (1996). Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukocyte Biol. 59, 797-803.
32. DE CATERINA, R., LIBBY, P., PENG, H.B., THANNICKAL, V.J., RAJAVASHISTH, T.B., GIMBRONE, M.A., Jr., SHIN, W.S., and LIAO, J.K. (1995). Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60-68.
33. SHIN, W.S., HONG, Y.H., PENG, H.B., DE CATERINA, R., LIBBY, P., and LIAO, J.K. (1996). Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271, 11317-11324.
34. THOMSEN, L.L., and MILES, D.W. (1998). Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 17, 107-118.
35. DEL POZO, V., DE ARRUDA-CHAVES, E., DE ANDRES, B., CARDABA, B., LOPEZ-FARRE, A., GALLARDO, S., CORTEGANO, L, VIDARTE, L., JURADO, A., SASTRE, J., PALOMINO, P., and LAHOZ, C. (1997). Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J. Immunol. 158, 859-864.
36. MURATA, J., CORRADIN, S.B., FELLEY-BOSCO, E., and JUILLERAT-JEANNERET, L. (1995). Involvement of a transforming-growth-factor-beta-like molecule in tumor cell-derived inhibition of nitric-oxide synthesis in cerebral endothelial cells. Int. J. Cancer 62, 743-748.
37. UMANSKY, V., ROCHA, M., and SCHIRRMACHER, V. (1996). Liver endothelial cells: participation in host response to lymphoma metastasis. Cancer Metastasis Rev. 15, 273-279.
38. XIE, K., and FIDLER, I.J. (1998). Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 17, 55-75.
39. FIDLER, I.J., GRUYS, E., CIFONE, M.A., BARNES, Z., and BUCANA, C. (1981). Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst. 67, 947-956.
40. DONG, Z., STAROSELSKY, A.H., QI, X., XIE, K., and FIDLER, I.J. (1994). Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789-793.
41. TALMADGE, J.E., and FIDLER, IJ. (1982). Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst. 69, 975-980.
42. HANSEN, M.B., NIELSEN, S.E., and BERG, K. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
43. DING, A.H., NATHAN, C.F., and STUEHR, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
44. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloro-form extraction. Anal. Biochem. 162, 156-159.
45. ALWINE, J.C., KEMP, D.J., and STARK, G.R. (1977). Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc. Natl. Acad. Sci. USA 74, 5350-5354.
46. MARZLUFF, W.F., Jr. (1978). Transcription of RNA in isolated nuclei. Methods Cell Biol. 19, 317-332.
47. GREGORY, B., SAVING, R., and CILIBERTO, G. (1994). A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP). J. Immunol. Methods 170, 47-56.
48. STAROSELSKY, A.M., PATHAK, S., CHERNAJOVSKY, Y., TUCKER, S.L., and FIDLER, I.J. (1991). Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res. 51, 6292-6298.
49. ROONEY, D.E., and CZEPULKOWSKI, B.H. (1992). Prenatal diagnosis and tissue cultures. In: Human Cytogenetics: A Practical Approach. D.E. Rooney and B.H. Czepulkowski (eds.) New York: IRL Press, pp. 55-89.
50. BENN, P.A., and PERLE, M.A. (1992). Chromosomal staining and banding techniques. In: Human Cytogenetics: A Practical Approach. D.E. Rooney and B.H. Czepulkowski (eds.) New York: IRL Press, pp. 91-117.
51. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (eds.) (1989). Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
52. OHMORI, Y., and HAMILTON, T.A. (1995). The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 154, 5235-5244.
53. JUANG, S.-H., XIE, K., XU, L., WANG, Y., YONEDA, J., and FIDLER, I.J. (1997). Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma. Cancer Biother. Radiopharm. 12, 167-175.
54. KIMURA, T., NAKAYAMA, K., PENNINGER, J., KITAGAWA, M., HARADA, H., MATSUYAMA, T., TANAKA, N., KAMIJO, R., VILCEK, J., MAK, T.W., et al. (1994). Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264, 1921-1924.
55. BRINKEN, V., RUFFNER, H., SCHULTZ, U., SCHWARZ, A., REIS, L.F., STREHLOW, I., DECKER, T., and STAEHELI, P. (1995). Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol. Cell. Biol. 15, 975-982.
56. NGUYEN, H., HISCOTT, J., and PITHA, P.M. (1997). The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8, 293-312.
57. ITO, C.Y., KAZANTSEV, A.G., and BALDWIN, A.S., Jr. (1994). Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res. 22, 3787-3792.
58. DE MARTIN, R., VANHOVE, B., CHENG, Q., HOFER, E., CSIZMADIA, V., WINKLER, H., and BACH, F.H. (1993). Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J. 12, 2773-2779.